Efficacy of Certolizumab pegol in patients with Psoriasis and Psoriatic arthritis
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2017 New trial record
- 01 Dec 2017 Preliminary results (n=45) assessing efficacy published in the Dermatology and Therapy.